{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:15:09Z","timestamp":1791976509144,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.aohep.2019.01.011","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:11:39Z","timestamp":1557360699000},"page":"765-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["\u201cHepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?\u201d"],"prefix":"10.1016","volume":"18","author":[{"given":"Daniel S.","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etel I.","family":"Saturansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Poncino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamila","family":"Mart\u00ednez-Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Abritta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ascimani-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerys","family":"Cravero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.01.011_bib0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid Arthritis","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2019.01.011_bib0190","first-page":"1","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/15360288.2014.959238","article-title":"Methotrexate: a gold standard for treatment of rheumatoid arthritis","volume":"28","author":"Shinde","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"6","key":"10.1016\/j.aohep.2019.01.011_bib0200","first-page":"CD000957","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Lopez-Olivo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aohep.2019.01.011_bib0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2019.01.011_bib0210","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid arthritis patients: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2019.01.011_bib0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bmj.1.5801.654","article-title":"Methotrexate hepatotoxicity psoriasis \u2013 comparison of different dose regimens","volume":"1","author":"Dahl","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.aohep.2019.01.011_bib0220","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","article-title":"Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study","volume":"44","author":"van Ede","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","article-title":"Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review","volume":"43","author":"Whittle","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.aohep.2019.01.011_bib0230","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0235","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.14.6774","article-title":"Practical guidelines for diagnosis and early management of drug-induced liver injury","volume":"14","author":"Tajiri","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0240","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2019.01.011_bib0245","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis. Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0255","first-page":"25","article-title":"Epidemiolog\u00eda, Diagn\u00f3stico, Control, Prevenci\u00f3n y Tratamiento del S\u00edndrome Metab\u00f3lico en Adultos","volume":"13","author":"Consenso Latinoamericano de la Asociaci\u00f3n Latinoamericana de Diabetes (ALAD)","year":"2010","journal-title":"Revista ALAD"},{"key":"10.1016\/j.aohep.2019.01.011_bib0260","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2019.01.011_bib0265","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0270","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2014II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"B\u00e9nichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0275","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and Psoriasis: 2009 National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0280","first-page":"3","article-title":"Gu\u00edas Argentinas de Pr\u00e1ctica Cl\u00ednica en el Tratamiento de la Artritis Reumatoidea","volume":"3","author":"Sociedad Argentina de Reumatolog\u00eda","year":"2008","journal-title":"Rev Argent Reumatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0285","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2019.01.011_bib0290","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.01.011_bib0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.1.5750.625","article-title":"Liver damage due to methotrexate in patients with psoriasis","volume":"1","author":"Dahl","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.aohep.2019.01.011_bib0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/1523-1747.ep12679887","article-title":"Effects of methotrexate on the liver in psoriasis","volume":"62","author":"Reese","year":"1974","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009748709102922","article-title":"Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis","volume":"16","author":"Szanto","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0310","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.1780311201","article-title":"Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate","volume":"31","author":"Aponte","year":"1988","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3748\/wjg.v13.i3.329","article-title":"Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists","volume":"13","author":"Andrade","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0320","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.01.011_bib0325","first-page":"112","article-title":"Enfermedades hep\u00e1ticas en artritis reumatoidea y artritis psoriasica","volume":"42","author":"Garc\u00eda","year":"2012","journal-title":"Acta Gastroent Latinoamer"},{"key":"10.1016\/j.aohep.2019.01.011_bib0330","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.01.011_bib0335","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0340","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bjd.14816","article-title":"British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of methotrexate for skin disease 2016","volume":"175","author":"Warren","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0345","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2340\/00015555-2599","article-title":"Methotrexate use and monitoring in patients with psoriasis: a consensus report based on a Danish Expert Meeting","volume":"97","author":"Raaby","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate guidelines: revised","volume":"38","author":"Roenigk","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aohep.2019.01.011_bib0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/anr.1780320202","article-title":"Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy","volume":"32","author":"Kremer","year":"1989","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.aohep.2019.01.011_bib0360","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119300742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119300742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:31:24Z","timestamp":1567611084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119300742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1665268119300742"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.01.011","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cHepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?\u201d","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}